As of 2024-12-14, the Intrinsic Value of Transmedics Group Inc (TMDX) is
8.98 USD. This TMDX valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y).
With the current market price of 64.26 USD, the upside of Transmedics Group Inc is
-86.00%.
The range of the Intrinsic Value is 4.71 - 14.99 USD
TMDX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(300.91) - (90.84) |
(136.15) |
-311.9% |
| DCF (Growth 10y) |
(142.78) - (472.09) |
(214.22) |
-433.4% |
| DCF (EBITDA 5y) |
4.71 - 14.99 |
8.98 |
-86.0% |
| DCF (EBITDA 10y) |
26.47 - 67.73 |
43.20 |
-32.8% |
| Fair Value |
4.86 - 4.86 |
4.86 |
-92.43% |
| P/E |
35.03 - 41.86 |
37.98 |
-40.9% |
| EV/EBITDA |
2.42 - 39.58 |
18.94 |
-70.5% |
| EPV |
(21.15) - (27.70) |
(24.42) |
-138.0% |
| DDM - Stable |
10.62 - 39.08 |
24.85 |
-61.3% |
| DDM - Multi |
(13.27) - (37.89) |
(19.65) |
-130.6% |
TMDX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2,156.57 |
| Beta |
1.72 |
| Outstanding shares (mil) |
33.56 |
| Enterprise Value (mil) |
2,335.00 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.32% |
| Cost of Debt |
7.89% |
| WACC |
8.24% |